Mild Autonomous Cortisol Excess: Clinical Trials

1 trial for Mild Autonomous Cortisol Excess, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Mild Autonomous Cortisol Excess: new trials by email Literature Review of Mild Autonomous Cortisol Excess trials Research Report on Mild Autonomous Cortisol Excess

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women
Elagolix - Mild Autonomous Cortisol Excess
Phase 4TerminatedIcahn School of Medicine at Mount Sinai42021-07-062025-03-18

Interventions

elagolix (1)

Sponsors

Icahn School of Medicine at Mount Sinai (1)

Countries

United States (1)

Top investigators

Alice C Levine (1)